HOME > BUSINESS > Article

Text Size

small

medium

large


Japan Univ., Firm Join Hands with MediciNova for COVID-19 Vaccine

Japan Univ., Firm Join Hands with MediciNova for COVID-19 Vaccine

   Tsu, Mie Pref., July 28 (Jiji Press)--Japan's Mie University and pharmaceutical company BioComo said Tuesday they have agreed with MediciNova Inc. of the United States to jointly develop a vaccine for the novel coronavirus.
   The university in the central prefecture of Mie and BioComo, based in the Mie town of Komono, have developed a gene that has the property of connecting with antibodies and a harmless virus strain that delivers proteins produced by the gene.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Approval Rating for Abe Cabinet Drops to 32.7% in Aug., 2nd Worst after 29.9%
ECONOMY
About 40% of Employees to Leave Ailing Electronics Retailer Laox
SPORTS
Golf Women: Shibuno Comes Tentative 126th on Suspended Scottish Open Day One
OTHER
1st-Ever 1945 A-Bombing Exhibition in Hawaii Open on Battleship Missouri

AFP-JIJI PRESS NEWS JOURNAL


Photos